Clinical Trials Logo
  1. Home
  2. Sepsis
  3. NCT05602896
  4. Details
NCT05602896 Clinical Trial

Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Sepsis Clinical Trial

Official title:
Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT05602896
Other study ID # 202207066
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 31, 2024
Est. completion date July 31, 2025

Study information
Verified date June 2024
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will advance the knowledge in the field by determining the effectiveness of discharge education regarding prevention of a new infection which is the highest cause of readmission for sepsis patient. In evaluating the impact care teams will develop a clearer link between specific home-based education interventions and infection prevention. This study is an exploratory study designed to identify whether patient education through an innovative teaching method can have an impact on readmissions. This study may the first of several based on findings from this initial, exploratory study.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date July 31, 2025
Est. primary completion date July 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Oncology patients discharged to home following a diagnosis of sepsis, severe sepsis or septic shock - Patient must have a mobile phone/device - English speakers - Age range 18 - 85 years Exclusion Criteria: - Less than 18 years of age and older than 85 years of age - No mobile phone/device - Non-English speaking - No diagnosis of sepsis, severe sepsis, or septic shock - Non-Oncology patient

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Sepsis education
The education program has been reviewed and approved by BJH Center for Practice Excellence

Locations
Country Name City State
n/a

Sponsors (3)
Lead Sponsor Collaborator
Washington University School of Medicine BJC HealthCare, Viven Health

Outcome
Type Measure Description Time frame Safety issue
Primary Readmission rates 4 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3

External Links